What did @daniellenstanton actually say?
She said testosterone made her "a little testy" after switching from cream to injections, with irritability showing up early in treatment at a low dose, then fading as her body adjusted over time. That's a pretty measured, personal account. She's not claiming testosterone turns everyone into a rage monster. She's describing a transitional phase she noticed in herself and wanted to be transparent about for people asking similar questions.
Worth noting: she's been on testosterone cream for approximately nine years and injections for only six months. So the moodiness she describes is specifically tied to the delivery method switch, not to testosterone use broadly. That distinction matters, and she actually makes it herself.
Does the science back this up?
Mostly, yes. The mood connection to testosterone is real, but it's more complicated than "more testosterone equals more irritability." The research points to hormonal fluctuations, not sustained high levels, as the more likely culprit for mood disruption.
Injectable testosterone, particularly short-acting esters, creates a peak-and-trough pattern in serum levels that transdermal delivery largely avoids. A 2020 study by Khera et al. in the Journal of Sexual Medicine noted that delivery method significantly affects symptom stability, with transdermal formulations producing more consistent hormone levels. When you move from a cream that delivers steady low-level absorption to injections that spike and drop, you're essentially asking your nervous system to adapt to a new hormonal rhythm. The brain's androgen receptors, especially in limbic areas tied to emotional regulation, are sensitive to that variability. A 2016 review by Zarrouf et al. in the Journal of Psychiatric Practice found that while testosterone can improve mood in hypogonadal patients long-term, the early adjustment phase and fluctuating levels can temporarily worsen irritability in some individuals.
What did they get wrong (or right)?
She got the core observation right. Early irritability during testosterone initiation or delivery-method changes is documented, not imagined. Her framing that "the longer you're on it, your body gets used to it" is also broadly consistent with what the literature shows about adaptation over weeks to months.
What she doesn't address, and this is a gap worth flagging, is that mood changes during testosterone therapy in women can also involve estrogen conversion. Testosterone aromatizes to estradiol, and estrogen shifts have their own significant mood implications. A 2019 study by Davis et al. in The Lancet Diabetes and Endocrinology found that testosterone therapy in women produced measurable improvements in sexual function but noted that individual hormonal responses, including estrogen conversion rates, varied widely. If someone experiences mood symptoms, that hormonal interplay (the testosterone-to-estrogen conversion piece) deserves clinical attention, not just patience.
She also doesn't mention injection timing or frequency, which is a real variable. Weekly versus biweekly injections can produce meaningfully different peak-and-trough curves. That's not a criticism of her experience, but it's clinically relevant context she leaves out.
What should you actually know?
If you're switching from transdermal testosterone to injections and notice mood changes, that's a documented phenomenon, not a sign that testosterone is wrong for you. But it's also not something to just white-knuckle through without telling your prescriber.
Injection frequency, ester type, and dose all affect how pronounced the hormonal swings are. Shorter injection intervals can reduce peak-to-trough variability. A provider who's paying attention should be monitoring both testosterone and estradiol levels, not just checking whether your total testosterone hit a target number. Mood is a clinical signal, not just a personal complaint.
Her personal timeline, nine years on cream, six months on injections, is also a reminder that hormone therapy is a long-term commitment with ongoing adjustments. Anyone selling you a "set it and forget it" version of TRT is not describing how this actually works in practice. Response changes over time, delivery preferences evolve, and regular lab monitoring is not optional.
Bottom line: is this worth watching?
Yes, with caveats. She's sharing a genuine, nuanced personal experience and being clear that it's her own, not a universal rule. The observation about early moodiness with injections is scientifically plausible. What this video can't do, and isn't trying to do, is replace a clinical conversation about why mood changes happen mechanistically or what to do about them. If you're experiencing mood symptoms on testosterone, talk to your prescriber. "My body just needs to adjust" might be true. It also might not be the whole picture.